Rennova Health, Inc. · OTC:RNVA
Rennova Health — Investor Presentation (May 2016)
23 slides from Rennova Health's investor presentation, May 3, 2016
Slide 1: Diagnostics and supportive software solutions to healthcare providers
Nasdaq: RNVA Diagnostics and supportive software solutions to healthcare providers. May 2 nd 2016
Slide 2: Forward looking Statements and Non-GAAP Information
This presentation includes forward - looking statements about Rennova Health’s anticipated results that involve risks and uncertainties . Some of the information contained in this presentation, including statements as to industry trends and plans, objectives, expectations and strategy for the combin
Slide 3: We are Rennova Health: Healthcare is being transformed
3 We are Rennova Health Healthcare is being transformed
Slide 4: Key Investment Highlights
Rennova Health, Inc . Phone : 844 - RENNOVA 400 South Australian Avenue Email : info@rennovahealth.com 8th Floor www.rennovahealth.com West Palm Beach, FL 33401 4 Key Investment Highlights • Five - year history of operations with multiple significant milestones • Substantial and profitable revenues
Slide 5: Rennova Health offers a single source solution for Medical Providers
• The diagnostics sector has changed dramatically in the last few years • Paper records and faxes meant different vendors to a medical provider could function side by side without communication • Electronic platforms and integration have created a need for providers of solutions to communicate, effi
Slide 6: Single Source Solution: Clinical Lab Services, Revenue Cycle Management, Software Solutions
6 Clinical Lab S ervices Revenue Cycle Management Software S olutions Single Source Solution Rennova Health, Inc. offers a single source solution for Medical Providers 5 Clinical Laboratories Integrated Medical Billing Company Proprietary Lab ordering and reporting Laboratory Information System (LIS
Slide 7: 2015 Accomplishments
2015 Accomplishments Top three accomplishments: Merger & Nasdaq listing Supportive Software Development Completed Lab Development 7
Slide 8: Launched in 4th quarter 2015
Launched in 4 th quarter 2015 8
Slide 9: Management Team
• Seamus Lagan CEO 20 years experience in the restructuring, development and management of startup and small companies • Jason Adams CFO CFO in behavorial health sector and Senior Financial Management of public companies • Victoria Nemerson, Esq. Corporate Counsel 25 years experience as a trial and
Slide 10: Board of Directors
10 • Thomas Mika Chairman of Rennova, CEO of CollabRx (subsidiary) 10 years as Chairman and CEO of a Nasdaq listed Company. Oversaw a number of public offerings. Holds a Bachelor of Science degree in Microbiology, MBA Harvard • Seamus Lagan CEO 20 years experience in the restructuring, development a
Slide 11: History in Numbers
History in Numbers $3,993,000 $21,076,000 $41,889,000 $59,429,000 $37,887,000 $621,000 $4,183,000 $14,775,000 $19,749,000 $3,214,000 $- $10,000,000 $20,000,000 $30,000,000 $40,000,000 $50,000,000 $60,000,000 $70,000,000 2011 2012 2013 2014 2015 Adjusted Revenues Adjusted EBITDA Reconciliation of Adj
Slide 12: Capitalization at April 15, 2016
Capitalization at April 15, 2016 Common Shares Outstanding 14,782,557 Dilutive Potential Shares: Stock Options @ WAVG $6.41 1,822,675 Warrants @ WAVG $1.83 6,898,560 Convertible Debt 1,074,402 Convertible Preferred Stock 11,540,397 Total Dilutive Potential 21,336,034 Fully Diluted Common Shares Outs
Slide 13: Regulation G Reconciliation
13 (in thousands) 2011 2012 2013 2014 2015 GAAP Net Revenue 3,993$ 21,076$ 41,889$ 57,928$ 18,393$ Reserve for Aged Accounts Receivable - - - 1,501 19,494 Adjusted Revenues 3,993$ 21,076$ 41,889$ 59,429$ 37,887$ GAAP Pretax Income 415$ 3,228$ 13,829$ 15,382$ (43,759)$ Depreciation and Amortization 1
Slide 14: Drug and Alcohol Rehabilitation and Pain Management Markets
Drug and Alcohol Rehabilitation • Total Market Size – estimated at $35 Billion* • Large and growing number of facilities in a fragmented market • Between 14,500 to 16,700 outpatient clinics* Market growth from high demand: • Over 23 million Americans are addicted to alcohol and other drugs** • The n
Slide 15: Rennova Health Licensing Map as of April 29, 2016
RENNOVA HEALTH LICENSING MAP AS OF APRIL 29, 2016 . oe, e sms; on Applied for Medicaid Licens ; is ig Rennova Heath Unb Locator Ss olutions Driven by Innovation
Slide 16: Our Payers
16 Our Payers • Initiated Medicaid Licensing & Third Party Payer initiative in December 2015 o Applied for Medicaid Licenses in 31 States o As of April 29, 2016 possess Medicaid Licenses in 16 States • Current Third Party Insurance Payer Contracts o Blue Shield of California o Coventry (National Con
Slide 17: Strategy
Strategy 17
Slide 18: The Long Term Strategy
The Long Term Strategy Create a sustainable relationship with our customers to grow recurring revenue and provide value to our shareholders How? Build from a toxicology - focused company to: 1. A significant and diverse diagnostics business 2. Offering supportive software solutions that add value by
Slide 19: 2016 Goals
• Strengthen core diagnostic business o Capitalize on recent disruption in toxicology sector o Increase Clinical testing o Launch Pharmacogenomics testing o Launch DTC (direct to consumer) testing – StableSpot ™ initial ambition, testosterone • Accelerate growth and/or launch: o HTS supportive softw
Slide 20: Online Training Program Launch to deliver increased sales
Program Objectives : • Ensure consistency in messaging and information • Provide effective and easy to use platform • Make information accessible anytime and from anywhere • Enable opportunity for monitoring and assessment Initially for sales reps, but to be expanded over time for all employees. Goa
Slide 21: Opportunities in the Pipeline
Epinex Diagnostics Opportunities in the Pipeline Genomas Genomics based diagnostics - drug management solution Diabetes and Rapid diagnostic tests for providers & consumers 21
Slide 22: Key Investment Highlights and Contact
Rennova Health, Inc . Phone : 844 - RENNOVA 400 South Australian Avenue Email : info@rennovahealth.com 8th Floor www.rennovahealth.com West Palm Beach, FL 33401 22 Key Investment Highlights • Five - year history of operations with multiple significant milestones • Substantial and profitable revenues
Slide 23: Solutions Driven by Innovation
@ ‘Solutions Driven by Inno\ n